Viridian Therapeutics Inc. (VRDN) NASDAQ
$13.03 (1.22) (-8.56%)
Market Cap: $817.86M
As of 04/24/24 04:00 PM EDT. Market closed.
Viridian Therapeutics Inc. (VRDN)
NASDAQ
$13.03
(1.22) (-8.56%)
Market Cap: $817.86M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
miragen therapeutics, inc., (nasdaq: mgen), is a biopharmaceutical company discovering and developing innovative microrna (mirna)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. the company leverages in-house expertise in mirna biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
William Marshall
Full Time Employees
112
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
William Marshall
Full Time Employees
112
URL
Address
6200 Lookout Rd, Colorado, Boulder, 80301-3319.
PRICE CHART FOR VIRIDIAN THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$14.25
Days Range
$12.99 - $14.38
52 week range
$10.93 - $28.99
Volume
771,185
Avg. Volume (30 days)
757,273
Market Cap
$817.86M
Dividend Yield
-
P/E
(3.44)
Shares Outstanding
62,767,570
Open
-
Previous Close
$14.25
Days Range
$12.99 - $14.38
52 week range
$10.93 - $28.99
Volume
771,185
Avg. Volume (30 days)
757,273
Market Cap
$817.86M
Dividend Yield
-
P/E
(3.44)
Shares Outstanding
62,767,570
FINANCIAL STATEMENTS FOR VIRIDIAN THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR VIRIDIAN THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Fairmount Funds Management LLC | Director | Jan 22, 2024 | Buy | $21.00 | 476,190 | 9,999,990 | 1,839,954 | Jan 24, 2024, 06:44 PM |
| Meisner Lara | Chief Legal Officer | Jun 15, 2023 | Option Exercise | $23.03 | 2,269 | 52,255 | 32,240 | Jun 20, 2023, 05:23 PM |
| Meisner Lara | Chief Legal Officer | Jun 16, 2023 | Option Exercise | $23.03 | 27 | 622 | 29,998 | Jun 20, 2023, 05:23 PM |
| Meisner Lara | Chief Legal Officer | Jun 16, 2023 | Sale | $28.35 | 27 | 765 | 29,971 | Jun 20, 2023, 05:23 PM |
| Meisner Lara | Chief Legal Officer | Jun 15, 2023 | Sale | $28.02 | 2,269 | 63,577 | 29,971 | Jun 20, 2023, 05:23 PM |
| Meisner Lara | Chief Legal Officer | Jun 06, 2023 | Option Exercise | $18.51 | 5,126 | 94,882 | 35,097 | Jun 06, 2023, 07:41 PM |
| Meisner Lara | Chief Legal Officer | Jun 05, 2023 | Option Exercise | $18.51 | 499 | 9,236 | 30,470 | Jun 06, 2023, 07:41 PM |
| Meisner Lara | Chief Legal Officer | Jun 02, 2023 | Option Exercise | $14.00 | 1,875 | 26,250 | 31,846 | Jun 06, 2023, 07:41 PM |
| Meisner Lara | Chief Legal Officer | Jun 06, 2023 | Sale | $25.02 | 5,126 | 128,253 | 29,971 | Jun 06, 2023, 07:41 PM |
| Meisner Lara | Chief Legal Officer | Jun 05, 2023 | Sale | $25.03 | 499 | 12,490 | 29,971 | Jun 06, 2023, 07:41 PM |
| Meisner Lara | Chief Legal Officer | Jun 02, 2023 | Sale | $24.21 | 1,875 | 45,394 | 29,971 | Jun 06, 2023, 07:41 PM |
| Myers Scott Dunseth | Chief Executive Officer | Apr 12, 2023 | Buy | $25.37 | 4,000 | 101,479 | 259,500 | Apr 12, 2023, 07:05 PM |
| Myers Scott Dunseth | Chief Executive Officer | Mar 13, 2023 | Buy | $29.15 | 5,500 | 160,324 | 255,500 | Mar 13, 2023, 04:06 PM |
| Meisner Lara | General Counsel and Secretary | Mar 09, 2023 | Sale | $29.07 | 29,971 | 871,257 | 0 | Mar 10, 2023, 04:05 PM |
| Violin Jonathan | Chief Executive Officer | Feb 02, 2023 | Option Exercise | $0.15 | 50,000 | 7,500 | 530,905 | Feb 07, 2023, 06:35 PM |
| Violin Jonathan | Chief Executive Officer | Feb 02, 2023 | Sale | $36.80 | 50,000 | 1,840,000 | 480,905 | Feb 07, 2023, 06:35 PM |
| Violin Jonathan | Chief Executive Officer | Feb 02, 2023 | Sale | $36.80 | 50,000 | 1,840,000 | 430,905 | Feb 03, 2023, 06:12 PM |
| Meisner Lara | General Counsel and Secretary | Jan 23, 2023 | Option Exercise | $20.56 | 6,843 | 140,690 | 6,843 | Jan 25, 2023, 06:04 PM |
| Meisner Lara | General Counsel and Secretary | Jan 23, 2023 | Sale | $35.66 | 6,843 | 244,021 | 0 | Jan 25, 2023, 06:04 PM |
| Katz Barrett | Chief Medical Officer | Jan 17, 2023 | Option Exercise | $23.03 | 24,853 | 572,365 | 24,853 | Jan 18, 2023, 05:58 PM |
| Katz Barrett | Chief Medical Officer | Jan 13, 2023 | Option Exercise | $23.03 | 4,147 | 95,505 | 4,147 | Jan 18, 2023, 05:58 PM |
| Katz Barrett | Chief Medical Officer | Jan 17, 2023 | Sale | $37.21 | 24,853 | 924,780 | 0 | Jan 18, 2023, 05:58 PM |
| Katz Barrett | Chief Medical Officer | Jan 13, 2023 | Sale | $37.01 | 4,147 | 153,480 | 0 | Jan 18, 2023, 05:58 PM |
| Katz Barrett | Chief Medical Officer | Jan 10, 2023 | Option Exercise | $23.03 | 47,377 | 1,091,092 | 47,377 | Jan 11, 2023, 07:09 PM |
| Katz Barrett | Chief Medical Officer | Jan 09, 2023 | Option Exercise | $23.03 | 12,623 | 290,708 | 12,623 | Jan 11, 2023, 07:09 PM |
| Katz Barrett | Chief Medical Officer | Jan 09, 2023 | Sale | $33.04 | 12,623 | 417,064 | 0 | Jan 11, 2023, 07:09 PM |
| Katz Barrett | Chief Medical Officer | Jan 10, 2023 | Sale | $35.30 | 47,377 | 1,672,408 | 0 | Jan 11, 2023, 07:09 PM |
| Meisner Lara | General Counsel and Secretary | Dec 21, 2022 | Option Exercise | $23.03 | 16,326 | 375,988 | 16,326 | Dec 22, 2022, 04:42 PM |
| Meisner Lara | General Counsel and Secretary | Dec 20, 2022 | Option Exercise | $23.03 | 600 | 13,818 | 600 | Dec 22, 2022, 04:42 PM |
| Meisner Lara | General Counsel and Secretary | Dec 21, 2022 | Sale | $29.19 | 16,326 | 476,556 | 0 | Dec 22, 2022, 04:42 PM |
| Meisner Lara | General Counsel and Secretary | Dec 20, 2022 | Sale | $28.07 | 600 | 16,842 | 0 | Dec 22, 2022, 04:42 PM |
| Meisner Lara | General Counsel and Secretary | Dec 16, 2022 | Option Exercise | $23.03 | 1,297 | 29,870 | 1,297 | Dec 19, 2022, 07:22 PM |
| Meisner Lara | General Counsel and Secretary | Dec 15, 2022 | Option Exercise | $23.03 | 300 | 6,909 | 300 | Dec 19, 2022, 07:22 PM |
| Meisner Lara | General Counsel and Secretary | Dec 16, 2022 | Sale | $28.44 | 1,297 | 36,887 | 0 | Dec 19, 2022, 07:22 PM |
| Meisner Lara | General Counsel and Secretary | Dec 15, 2022 | Sale | $28.08 | 300 | 8,424 | 0 | Dec 19, 2022, 07:22 PM |
| Meisner Lara | General Counsel and Secretary | Dec 12, 2022 | Option Exercise | $23.03 | 600 | 13,818 | 600 | Dec 14, 2022, 08:56 PM |
| Meisner Lara | General Counsel and Secretary | Dec 14, 2022 | Option Exercise | $23.03 | 15,656 | 360,558 | 15,656 | Dec 14, 2022, 08:56 PM |
| Meisner Lara | General Counsel and Secretary | Dec 12, 2022 | Sale | $28.05 | 600 | 16,830 | 0 | Dec 14, 2022, 08:56 PM |
| Meisner Lara | General Counsel and Secretary | Dec 14, 2022 | Sale | $28.12 | 15,656 | 440,247 | 0 | Dec 14, 2022, 08:56 PM |
| Meisner Lara | General Counsel and Secretary | Nov 15, 2022 | Option Exercise | $14.00 | 8,125 | 113,750 | 8,125 | Nov 16, 2022, 06:45 PM |
| Meisner Lara | General Counsel and Secretary | Nov 15, 2022 | Sale | $22.05 | 8,125 | 179,156 | 0 | Nov 16, 2022, 06:45 PM |
| Fairmount Funds Management LLC | Director | Aug 17, 2022 | Buy | $23.50 | 425,531 | 9,999,979 | 1,363,764 | Aug 19, 2022, 04:32 PM |
| Violin Jonathan | Chief Executive Officer | Jun 01, 2022 | Sale | $12.20 | 30,000 | 366,000 | 480,905 | Jun 02, 2022, 05:29 PM |
| Violin Jonathan | Chief Executive Officer | May 02, 2022 | Sale | $13.04 | 30,000 | 391,200 | 510,905 | May 04, 2022, 05:23 PM |
| Violin Jonathan | Chief Executive Officer | Apr 04, 2022 | Sale | $18.93 | 3,600 | 68,148 | 540,905 | Apr 05, 2022, 06:09 PM |
| Violin Jonathan | Chief Executive Officer | Apr 01, 2022 | Sale | $18.92 | 26,400 | 499,488 | 544,505 | Apr 05, 2022, 06:09 PM |
| Violin Jonathan | Chief Executive Officer | Mar 02, 2022 | Sale | $17.36 | 11,106 | 192,800 | 570,905 | Mar 03, 2022, 04:48 PM |
| Violin Jonathan | Chief Executive Officer | Mar 01, 2022 | Sale | $17.82 | 18,894 | 336,691 | 582,011 | Mar 03, 2022, 04:48 PM |
| Violin Jonathan | Chief Executive Officer | Feb 01, 2022 | Sale | $19.55 | 16,751 | 327,482 | 614,154 | Feb 03, 2022, 06:11 PM |
| Violin Jonathan | Chief Executive Officer | Feb 03, 2022 | Sale | $19.16 | 909 | 17,416 | 600,905 | Feb 03, 2022, 06:11 PM |
| Violin Jonathan | Chief Executive Officer | Feb 02, 2022 | Sale | $18.47 | 12,340 | 227,920 | 601,814 | Feb 03, 2022, 06:11 PM |
| Frazier Life Sciences Public Fund, L.P. | 10% Owner | Sep 23, 2021 | Buy | $11.00 | 200,000 | 2,200,000 | 1,505,200 | Sep 28, 2021, 07:46 PM |
| Fairmount Funds Management LLC | Director | Sep 21, 2021 | Buy | $11.00 | 909,000 | 9,999,000 | 938,233 | Sep 23, 2021, 09:30 AM |
| Logos Global Master Fund LP | 10% Owner | Nov 13, 2020 | Buy | $14.84 | 126,667 | 1,879,599 | 550,000 | Nov 16, 2020, 06:23 PM |
| Logos Global Master Fund LP | 10% Owner | Nov 09, 2020 | Buy | $1.12 | 350,000 | 390,885 | 6,350,000 | Nov 16, 2020, 06:23 PM |
| Leverone Jason A. | CFO, Treasurer & Secretary | Mar 13, 2020 | Option Exercise | $0.57 | 11,249 | 6,412 | 48,829 | Mar 17, 2020, 04:22 PM |
| Leverone Jason A. | CFO, Treasurer & Secretary | Aug 23, 2019 | Option Exercise | $0.57 | 3,093 | 1,763 | 36,330 | Aug 23, 2019, 06:16 PM |
| Hughes Thomas E. | Director | Oct 11, 2018 | Buy | $4.77 | 10,000 | 47,697 | 12,827 | Oct 12, 2018, 04:38 PM |
| Leverone Jason A. | CFO, Treasurer & Secretary | Aug 07, 2018 | Option Exercise | $0.57 | 29,530 | 16,832 | 30,737 | Aug 09, 2018, 04:18 PM |
| Marshall William Stuart | President & CEO | Feb 13, 2018 | Option Exercise | $0.57 | 115,818 | 66,016 | 265,646 | Feb 15, 2018, 04:36 PM |
| Levy Adam Scott | Chief Business Officer | Feb 13, 2018 | Buy | $5.50 | 9,090 | 49,995 | 10,540 | Feb 13, 2018, 05:02 PM |
| Booth Bruce | Director | Feb 13, 2018 | Buy | $5.50 | 545,454 | 2,999,997 | 1,351,090 | Feb 13, 2018, 04:59 PM |
| Hughes Thomas E. | Director | Dec 20, 2017 | Sale | $8.00 | 12,000 | 96,000 | 2,827 | Dec 22, 2017, 06:08 PM |
| Levy Adam Scott | Chief Business Officer | Jun 22, 2017 | Buy | $7.55 | 200 | 1,510 | 200 | Jun 23, 2017, 07:07 PM |
| LEFKOFF KYLE | Director | Mar 10, 2017 | Sale | $14.31 | 3,300 | 47,229 | 463,473 | Mar 13, 2017, 06:37 PM |
| LEFKOFF KYLE | Director | Mar 09, 2017 | Sale | $14.38 | 2,500 | 35,961 | 466,773 | Mar 13, 2017, 06:37 PM |
| LEFKOFF KYLE | Director | Mar 08, 2017 | Sale | $14.70 | 5,000 | 73,514 | 469,273 | Mar 08, 2017, 05:12 PM |
| LEFKOFF KYLE | Director | Mar 06, 2017 | Sale | $15.75 | 10,000 | 157,463 | 474,881 | Mar 08, 2017, 05:12 PM |
| LEFKOFF KYLE | Director | Feb 27, 2017 | Sale | $13.79 | 1,500 | 20,687 | 486,531 | Feb 28, 2017, 06:52 PM |
| LEFKOFF KYLE | Director | Feb 24, 2017 | Sale | $14.04 | 6,500 | 91,252 | 488,031 | Feb 28, 2017, 06:52 PM |
| LEFKOFF KYLE | Director | Feb 28, 2017 | Sale | $13.54 | 2,258 | 30,580 | 484,273 | Feb 28, 2017, 06:52 PM |
| LEFKOFF KYLE | Director | Feb 23, 2017 | Sale | $13.65 | 1,800 | 24,566 | 494,531 | Feb 24, 2017, 07:07 PM |
| LEFKOFF KYLE | Director | Feb 22, 2017 | Sale | $14.36 | 4,102 | 58,886 | 496,331 | Feb 24, 2017, 07:07 PM |
| LEBOW BENNETT S | Director | Feb 13, 2017 | Option Exercise | $5.39 | 279,067 | 1,504,171 | 280,600 | Feb 13, 2017, 06:05 PM |
| Gonyer David A | Director | Feb 08, 2017 | Option Exercise | $7.65 | 1,200 | 9,180 | 1,899 | Feb 08, 2017, 08:50 PM |
| LEBOW BENNETT S | Director | Feb 03, 2017 | Option Exercise | $7.65 | 1,200 | 9,180 | 1,533 | Feb 07, 2017, 09:08 PM |
| Smith Robin L | Director | Feb 03, 2017 | Option Exercise | $7.65 | 1,200 | 9,180 | 1,900 | Feb 07, 2017, 09:08 PM |
| SEYMOUR TAMARA A | CFO, Secretary, Treasurer | Oct 31, 2016 | Option Exercise | $0.36 | 66,547 | 23,957 | 106,447 | Nov 02, 2016, 08:39 PM |
| Riccitelli Samuel D | President & CEO | Oct 31, 2016 | Option Exercise | $0.36 | 103,160 | 37,138 | 571,370 | Nov 02, 2016, 08:37 PM |
| SEYMOUR TAMARA A | CFO, Secretary, Treasurer | Aug 08, 2016 | Option Exercise | $0.49 | 10,484 | 5,085 | 26,994 | Aug 10, 2016, 06:01 PM |
| Riccitelli Samuel D | President & CEO | Jun 28, 2016 | Option Exercise | $0.46 | 64,835 | 29,824 | 474,530 | Jun 30, 2016, 04:56 PM |
| Riccitelli Samuel D | President & CEO | Feb 11, 2016 | Option Exercise | $0.46 | 54,268 | 24,963 | 415,114 | Feb 12, 2016, 05:13 PM |
| Riccitelli Samuel D | President & CEO | Nov 20, 2015 | Buy | $0.80 | 7,000 | 5,600 | 345,130 | Nov 23, 2015, 12:28 PM |
| Riccitelli Samuel D | President & CEO | Nov 19, 2015 | Buy | $0.78 | 7,000 | 5,460 | 338,130 | Nov 23, 2015, 12:28 PM |
| SEYMOUR TAMARA A | CFO, Secretary, Treasurer | Aug 04, 2015 | Option Exercise | $1.56 | 8,522 | 13,294 | 14,478 | Aug 05, 2015, 05:37 PM |
| Riccitelli Samuel D | President and CEO | Jun 19, 2015 | Option Exercise | $1.51 | 46,036 | 69,514 | 331,130 | Jun 23, 2015, 05:35 PM |
| Riccitelli Samuel D | President and CEO | Apr 08, 2015 | Option Exercise | $2.08 | 119,842 | 249,271 | 252,914 | Apr 10, 2015, 05:39 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Fairmount Funds Management LLC | Director | 01/22/2024 | 9,999,990 |
| Meisner Lara | Chief Legal Officer | 06/15/2023 | 52,255 |
| Meisner Lara | Chief Legal Officer | 06/16/2023 | 622 |
| Meisner Lara | Chief Legal Officer | 06/16/2023 | 765 |
| Meisner Lara | Chief Legal Officer | 06/15/2023 | 63,577 |
| Meisner Lara | Chief Legal Officer | 06/06/2023 | 94,882 |
| Meisner Lara | Chief Legal Officer | 06/05/2023 | 9,236 |
| Meisner Lara | Chief Legal Officer | 06/02/2023 | 26,250 |
| Meisner Lara | Chief Legal Officer | 06/06/2023 | 128,253 |
| Meisner Lara | Chief Legal Officer | 06/05/2023 | 12,490 |
| Meisner Lara | Chief Legal Officer | 06/02/2023 | 45,394 |
| Myers Scott Dunseth | Chief Executive Officer | 04/12/2023 | 101,479 |
| Myers Scott Dunseth | Chief Executive Officer | 03/13/2023 | 160,324 |
| Meisner Lara | General Counsel and Secretary | 03/09/2023 | 871,257 |
| Violin Jonathan | Chief Executive Officer | 02/02/2023 | 7,500 |
| Violin Jonathan | Chief Executive Officer | 02/02/2023 | 1,840,000 |
| Violin Jonathan | Chief Executive Officer | 02/02/2023 | 1,840,000 |
| Meisner Lara | General Counsel and Secretary | 01/23/2023 | 140,690 |
| Meisner Lara | General Counsel and Secretary | 01/23/2023 | 244,021 |
| Katz Barrett | Chief Medical Officer | 01/17/2023 | 572,365 |
| Katz Barrett | Chief Medical Officer | 01/13/2023 | 95,505 |
| Katz Barrett | Chief Medical Officer | 01/17/2023 | 924,780 |
| Katz Barrett | Chief Medical Officer | 01/13/2023 | 153,480 |
| Katz Barrett | Chief Medical Officer | 01/10/2023 | 1,091,092 |
| Katz Barrett | Chief Medical Officer | 01/09/2023 | 290,708 |
| Katz Barrett | Chief Medical Officer | 01/09/2023 | 417,064 |
| Katz Barrett | Chief Medical Officer | 01/10/2023 | 1,672,408 |
| Meisner Lara | General Counsel and Secretary | 12/21/2022 | 375,988 |
| Meisner Lara | General Counsel and Secretary | 12/20/2022 | 13,818 |
| Meisner Lara | General Counsel and Secretary | 12/21/2022 | 476,556 |
| Meisner Lara | General Counsel and Secretary | 12/20/2022 | 16,842 |
| Meisner Lara | General Counsel and Secretary | 12/16/2022 | 29,870 |
| Meisner Lara | General Counsel and Secretary | 12/15/2022 | 6,909 |
| Meisner Lara | General Counsel and Secretary | 12/16/2022 | 36,887 |
| Meisner Lara | General Counsel and Secretary | 12/15/2022 | 8,424 |
| Meisner Lara | General Counsel and Secretary | 12/12/2022 | 13,818 |
| Meisner Lara | General Counsel and Secretary | 12/14/2022 | 360,558 |
| Meisner Lara | General Counsel and Secretary | 12/12/2022 | 16,830 |
| Meisner Lara | General Counsel and Secretary | 12/14/2022 | 440,247 |
| Meisner Lara | General Counsel and Secretary | 11/15/2022 | 113,750 |
| Meisner Lara | General Counsel and Secretary | 11/15/2022 | 179,156 |
| Fairmount Funds Management LLC | Director | 08/17/2022 | 9,999,979 |
| Violin Jonathan | Chief Executive Officer | 06/01/2022 | 366,000 |
| Violin Jonathan | Chief Executive Officer | 05/02/2022 | 391,200 |
| Violin Jonathan | Chief Executive Officer | 04/04/2022 | 68,148 |
| Violin Jonathan | Chief Executive Officer | 04/01/2022 | 499,488 |
| Violin Jonathan | Chief Executive Officer | 03/02/2022 | 192,800 |
| Violin Jonathan | Chief Executive Officer | 03/01/2022 | 336,691 |
| Violin Jonathan | Chief Executive Officer | 02/01/2022 | 327,482 |
| Violin Jonathan | Chief Executive Officer | 02/03/2022 | 17,416 |
| Violin Jonathan | Chief Executive Officer | 02/02/2022 | 227,920 |
| Frazier Life Sciences Public Fund, L.P. | 10% Owner | 09/23/2021 | 2,200,000 |
| Fairmount Funds Management LLC | Director | 09/21/2021 | 9,999,000 |
| Logos Global Master Fund LP | 10% Owner | 11/13/2020 | 1,879,599 |
| Logos Global Master Fund LP | 10% Owner | 11/09/2020 | 390,885 |
| Leverone Jason A. | CFO, Treasurer & Secretary | 03/13/2020 | 6,412 |
| Leverone Jason A. | CFO, Treasurer & Secretary | 08/23/2019 | 1,763 |
| Hughes Thomas E. | Director | 10/11/2018 | 47,697 |
| Leverone Jason A. | CFO, Treasurer & Secretary | 08/07/2018 | 16,832 |
| Marshall William Stuart | President & CEO | 02/13/2018 | 66,016 |
| Levy Adam Scott | Chief Business Officer | 02/13/2018 | 49,995 |
| Booth Bruce | Director | 02/13/2018 | 2,999,997 |
| Hughes Thomas E. | Director | 12/20/2017 | 96,000 |
| Levy Adam Scott | Chief Business Officer | 06/22/2017 | 1,510 |
| LEFKOFF KYLE | Director | 03/10/2017 | 47,229 |
| LEFKOFF KYLE | Director | 03/09/2017 | 35,961 |
| LEFKOFF KYLE | Director | 03/08/2017 | 73,514 |
| LEFKOFF KYLE | Director | 03/06/2017 | 157,463 |
| LEFKOFF KYLE | Director | 02/27/2017 | 20,687 |
| LEFKOFF KYLE | Director | 02/24/2017 | 91,252 |
| LEFKOFF KYLE | Director | 02/28/2017 | 30,580 |
| LEFKOFF KYLE | Director | 02/23/2017 | 24,566 |
| LEFKOFF KYLE | Director | 02/22/2017 | 58,886 |
| LEBOW BENNETT S | Director | 02/13/2017 | 1,504,171 |
| Gonyer David A | Director | 02/08/2017 | 9,180 |
| LEBOW BENNETT S | Director | 02/03/2017 | 9,180 |
| Smith Robin L | Director | 02/03/2017 | 9,180 |
| SEYMOUR TAMARA A | CFO, Secretary, Treasurer | 10/31/2016 | 23,957 |
| Riccitelli Samuel D | President & CEO | 10/31/2016 | 37,138 |
| SEYMOUR TAMARA A | CFO, Secretary, Treasurer | 08/08/2016 | 5,085 |
| Riccitelli Samuel D | President & CEO | 06/28/2016 | 29,824 |
| Riccitelli Samuel D | President & CEO | 02/11/2016 | 24,963 |
| Riccitelli Samuel D | President & CEO | 11/20/2015 | 5,600 |
| Riccitelli Samuel D | President & CEO | 11/19/2015 | 5,460 |
| SEYMOUR TAMARA A | CFO, Secretary, Treasurer | 08/04/2015 | 13,294 |
| Riccitelli Samuel D | President and CEO | 06/19/2015 | 69,514 |
| Riccitelli Samuel D | President and CEO | 04/08/2015 | 249,271 |
Load More Insider Transactions
FUNDS WITH A POSITION IN VIRIDIAN THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 3,426,450 | 0.0019% | 14.48% | Other |
| MAVERICK CAPITAL LTD | 2,325,841 | 1.02% | New | Growth At A Reasonable Price, Growth |
| VIVO CAPITAL, LLC | 1,678,207 | 2.31% | No change | Other |
| YIHENG CAPITAL MANAGEMENT, L.P. | 1,228,534 | 1.54% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 994,468 | 0.00227% | 15.76% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 41,214 | 0.00169% | 195.04% | Event Driven |
| ALPS ADVISORS INC | 34,854 | 0.00597% | 8.03% | Other |
| TUDOR INVESTMENT CORP ET AL | 30,218 | 0.0053% | New | Event Driven, Other |
| UBS OCONNOR LLC | 30,000 | 0.05% | -64.64% | Value |
| RENAISSANCE TECHNOLOGIES LLC | 13,400 | 0.00045% | -79.45% | Other |
CHANGE IN SHARES OUTSTANDING FOR VIRIDIAN THERAPEUTICS INC
STOCK BUYBACKS FOR VIRIDIAN THERAPEUTICS INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
14.19%
1Q
06/30/2023
15.25%
2Q
03/31/2023
18.01%
3Q
09/30/2022
47.74%
5Q
06/30/2022
79.56%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VIRIDIAN THERAPEUTICS INC
LOADING...